C4 Therapeutics, Inc.CCCCNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P89
Within normal range
vs 2Y Ago
1.3x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 29.04% |
| Q3 2025 | -158.83% |
| Q2 2025 | 63.78% |
| Q1 2025 | -85.62% |
| Q4 2024 | 25.70% |
| Q3 2024 | -385.18% |
| Q2 2024 | 72.55% |
| Q1 2024 | 24.54% |
| Q4 2023 | 21.81% |
| Q3 2023 | -61.64% |
| Q2 2023 | 42.65% |
| Q1 2023 | -13.72% |
| Q4 2022 | -3.95% |
| Q3 2022 | -26.24% |
| Q2 2022 | 16.55% |
| Q1 2022 | -3.60% |
| Q4 2021 | -39.84% |
| Q3 2021 | -1.98% |
| Q2 2021 | 27.80% |
| Q1 2021 | -15.76% |
| Q4 2020 | -49.06% |
| Q3 2020 | 0.99% |
| Q2 2020 | 12.43% |
| Q1 2020 | -61.74% |
| Q4 2019 | -30.43% |
| Q3 2019 | -121.40% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |